In the News - News
From: LiveScience
Teens who take longer to reach their full height may be at increased risk for certain types of brain tumors later in life, a new study suggests. It's possible that these people's bodies produce a lower level of growth hormones over a prolonged period, which may confer a higher risk of tumors than a higher level of growth hormones over a short period, said Rebecca Little, a and doctoral student at the University of Alabama at Birmingham.
Teens who take longer to reach their full height may be at increased risk for certain types of brain tumors later in life, a new study suggests. It's possible that these people's bodies produce a lower level of growth hormones over a prolonged period, which may confer a higher risk of tumors than a higher level of growth hormones over a short period, said Rebecca Little, a and doctoral student at the University of Alabama at Birmingham.
Several UAB art and art history students and faculty members recently took part in honoring four members of the Alabama Air National Guard who were killed during the ill-fated, CIA-backed attempt to invade Fidel Castro's Cuba at the Bay of Pigs in 1961. They painted new art on the nose of one of the planes flown by the Alabama Air National Guard's 117th Air Refueling Wing.
Suffice it to say that Prine’s April 11 concert at Birmingham’s Alys Stephens Center was a two-hour gem.
Researchers don’t know how long any study participants were married or how recently they were divorced or became widowed. But the results drive home the message that a person’s heart risks can’t be judged by physical measures alone—social factors and stress also matter, said Vera Bittner, a cardiologist at the University of Alabama at Birmingham.
That a good doctor-patient relationship can improve health outcomes has been shown before, for example in a study that showed diabetic patients are more successful at monitoring their blood sugar when their doctor is more empathetic, said Rodney Tucker, MD, chief experience officer for the University of Alabama at Birmingham Health System.
For Dr. Michael Saag, the director of the Center for AIDS Research at the University of Alabama at Birmingham, the new drugs eliminate the need to use interferon altogether. “I don’t plan on using interferon again unless I can help it,” he told IBT, pointing to the drug’s harsh side effects, toxicity and relative inefficacy.
The Birmingham Business Alliance is performing better than its peer cities in two-thirds of its 12 key measurements, but its chief executive said there is plenty of room for improvement.
“Specifically, we were able to demonstrate that established fibrosis in lungs of aged mice is partially reversed by administration of GKT137831, a new NOX inhibitor from Genkyotex,” explained Victor J. Thannickal, MD, Professor of Medicine and Pathology, Director, Division of Pulmonary, Allergy, and Critical Care, University of Alabama at Birmingham.
"Failure of this trial to reach its primary efficacy endpoint has forced me (and everybody else) to rethink this issue. Much more clinical and preclinical research is needed before we can define the role of renal denervation in the management of hypertension and its complications/comorbidities.Suzanne Oparil, MD, University of Alabama at Birmingham.
Researchers at the University of Alabama at Birmingham report a genetically engineered herpes simplex viral therapy is safe when used in conjunction with radiation in the treatment of malignant gliomas, one of the most deadly forms of brain cancer.